fluoxetine has been researched along with Bulimia in 84 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study assessed the long-term effects of group behavioral treatment plus individual cognitive behavioral therapy (CBT) and/or fluoxetine in binge eating disorder (BED) patients." | 9.12 | Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. ( Devlin, MJ; Goldfein, JA; Liu, L; Petkova, E; Walsh, BT, 2007) |
| "This open clinical trial examined the feasibility, tolerability, and efficacy of treating adolescents who suffer from bulimia nervosa with fluoxetine." | 9.10 | An open trial of fluoxetine for adolescents with bulimia nervosa. ( Davies, M; Devlin, MJ; Kotler, LA; Walsh, BT, 2003) |
| "The efficacy of fluoxetine in the acute management of bulimia nervosa is well established; however, few controlled studies have examined whether continuation of pharmacotherapy provides protection from relapse." | 9.10 | A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. ( Halmi, KA; Koke, SC; Lee, JS; Romano, SJ; Sarkar, NP, 2002) |
| "A randomized, placebo-controlled study was conducted examining the singular and combined effects of fluoxetine and a self-help manual on suppressing bulimic behaviors in women with bulimia nervosa." | 9.09 | The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa. ( Al-Banna, M; Crosby, R; Fletcher, L; Hanson, K; Mitchell, JE; Mussell, MP; Seim, H, 2001) |
| "The median frequency of binge eating in the previous 28 days declined from 22 to four episodes in the fluoxetine group but increased from 15 to 18 episodes in the placebo group." | 9.09 | Fluoxetine for bulimia nervosa following poor response to psychotherapy. ( Agras, WS; Chally, MK; Devlin, MJ; Fairburn, CG; Kahn, C; Walsh, BT; Wilson, GT, 2000) |
| "Two parallel, multicenter, double-blind, randomized, placebo-controlled fluoxetine clinical trials were retrospectively analyzed to determine the effect of comorbid depression on bulimia treatment response." | 9.09 | Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression. ( al-Banna, M; Ascroft, RC; Goldstein, DJ; Wilson, MG, 1999) |
| "A large collaborative 8-week study has shown fluoxetine to be effective and safe in treating patients with bulimia nervosa." | 9.08 | Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. ( Goldstein, DJ; Potvin, JH; Rampey, AH; Thompson, VL; Wilson, MG, 1995) |
| "This study compared and combined fluoxetine and individual cognitive behavioral therapy in the treatment of bulimia nervosa." | 9.08 | A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. ( Clewes, J; Davis, R; Goldbloom, DS; Heinmaa, M; Olmsted, M; Rockert, W; Shaw, B, 1997) |
| "Patients with bulimia nervosa have been reported to respond to treatment with the serotonin uptake inhibitor fluoxetine." | 9.08 | Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa. ( Linnoila, M; Naukkarinen, H; Rawlings, RR; Rissanen, A; Virkkunen, M, 1998) |
| "Three hundred eighty-two women meeting DSM-III-R criteria for bulimia nervosa participated in a multicenter, double-blind, randomized clinical trial of placebo, 20 mg of fluoxetine, and 60 mg of fluoxetine for 8 weeks." | 9.07 | Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change. ( Goldbloom, DS; Olmsted, MP, 1993) |
| "We administered an open trial of fluoxetine to 31 patients with DSM-III-R anorexia nervosa." | 9.07 | An open trial of fluoxetine in patients with anorexia nervosa. ( Bulik, CM; Hsu, LK; Kaye, WH; Weltzin, TE, 1991) |
| "Fluoxetine had a positive effect on bulimia nervosa but none on compulsive water drinking." | 7.70 | Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking. ( Dan, B; Fontaine, E; Kornreich, C; Pelc, I; Verbanck, P, 1998) |
| "Data from United States Investigational New Drug double-blind, placebo-controlled fluoxetine clinical trials in bulimia nervosa were analyzed comprehensively to assess the potential association between fluoxetine treatment and suicidality in 785 patients with DSM-III-R bulimia nervosa." | 7.68 | Lack of association between fluoxetine and suicidality in bulimia nervosa. ( Beasley, CM; Masica, DN; Potvin, JH; Rampey, AH; Thompson, VL; Wheadon, DE, 1992) |
| "The results of a small study using fluoxetine in the treatment of bulimia nervosa are presented." | 7.67 | Fluoxetine as a treatment for bulimia nervosa. ( Freeman, CP; Hampson, M, 1987) |
| "Fluoxetine was not superior to placebo, CBT+fluoxetine and CBT+placebo did not differ, and both CBT conditions were superior to fluoxetine and to placebo." | 6.71 | Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. ( Grilo, CM; Masheb, RM; Wilson, GT, 2005) |
| "Fluoxetine treatment was associated with greater reduction in depressive symptoms (p<0." | 6.71 | Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. ( Bellace, D; Carino, J; Devlin, MJ; Dobrow, I; Goldfein, JA; Jiang, H; Kamenetz, C; Mayer, L; Petkova, E; Raizman, PS; Walsh, BT; Wolk, S, 2005) |
| " Fluoxetine at 20 mg/d produced an effect between that of the 60-mg/d dosage and that of placebo." | 6.67 | Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. ( , 1992) |
| "Cyproheptadine has been used to counteract these side effects." | 5.28 | Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. ( Goldbloom, DS; Kennedy, SH, 1991) |
| "The purpose of this study was to establish whether vomiting bulimic and/or non-bulimic depressive patients, both treated with the serotonin reuptake inhibitor SI-5-HT (fluoxetine), have differing proportions of inorganic components (specifically, sodium, potassium and calcium) in their parotid salivary gland secretions, than in the average population." | 5.17 | Parotid gland flow activity and inorganic composition in purging bulimic patients treated with fluoxetine. ( Linden, RW; Paszynska, E; Rajewski, A; Slopien, A, 2013) |
| "This study assessed the long-term effects of group behavioral treatment plus individual cognitive behavioral therapy (CBT) and/or fluoxetine in binge eating disorder (BED) patients." | 5.12 | Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up. ( Devlin, MJ; Goldfein, JA; Liu, L; Petkova, E; Walsh, BT, 2007) |
| " Patients assigned to fluoxetine attended more physician visits, exhibited a greater reduction in binge eating and vomiting, and had a greater improvement in psychological symptoms than those assigned to placebo." | 5.11 | Treatment of bulimia nervosa in a primary care setting. ( Fairburn, CG; Mickley, D; Parides, MK; Sysko, R; Walsh, BT, 2004) |
| "Patients with broadly defined bulimia nervosa were enrolled in a double-blind, placebo-controlled treatment study of fluoxetine, with and without guided self-help." | 5.11 | Eating Disorder Examination-Questionnaire as a measure of change in patients with bulimia nervosa. ( Fairburn, CG; Sysko, R; Walsh, BT, 2005) |
| "The efficacy of fluoxetine in the acute management of bulimia nervosa is well established; however, few controlled studies have examined whether continuation of pharmacotherapy provides protection from relapse." | 5.10 | A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. ( Halmi, KA; Koke, SC; Lee, JS; Romano, SJ; Sarkar, NP, 2002) |
| "This open clinical trial examined the feasibility, tolerability, and efficacy of treating adolescents who suffer from bulimia nervosa with fluoxetine." | 5.10 | An open trial of fluoxetine for adolescents with bulimia nervosa. ( Davies, M; Devlin, MJ; Kotler, LA; Walsh, BT, 2003) |
| "The median frequency of binge eating in the previous 28 days declined from 22 to four episodes in the fluoxetine group but increased from 15 to 18 episodes in the placebo group." | 5.09 | Fluoxetine for bulimia nervosa following poor response to psychotherapy. ( Agras, WS; Chally, MK; Devlin, MJ; Fairburn, CG; Kahn, C; Walsh, BT; Wilson, GT, 2000) |
| " We present a case of bulimia nervosa and major depressive disorder, who had been treated with up to 60 mg/d fluoxetine for several weeks." | 5.09 | In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment. ( Asenbaum, S; Brücke, T; de Zwaan, M; Kasper, S; Pirker, W; Tauscher, J, 1999) |
| "Two parallel, multicenter, double-blind, randomized, placebo-controlled fluoxetine clinical trials were retrospectively analyzed to determine the effect of comorbid depression on bulimia treatment response." | 5.09 | Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression. ( al-Banna, M; Ascroft, RC; Goldstein, DJ; Wilson, MG, 1999) |
| "A randomized, placebo-controlled study was conducted examining the singular and combined effects of fluoxetine and a self-help manual on suppressing bulimic behaviors in women with bulimia nervosa." | 5.09 | The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa. ( Al-Banna, M; Crosby, R; Fletcher, L; Hanson, K; Mitchell, JE; Mussell, MP; Seim, H, 2001) |
| "This study compared and combined fluoxetine and individual cognitive behavioral therapy in the treatment of bulimia nervosa." | 5.08 | A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. ( Clewes, J; Davis, R; Goldbloom, DS; Heinmaa, M; Olmsted, M; Rockert, W; Shaw, B, 1997) |
| "A large collaborative 8-week study has shown fluoxetine to be effective and safe in treating patients with bulimia nervosa." | 5.08 | Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. ( Goldstein, DJ; Potvin, JH; Rampey, AH; Thompson, VL; Wilson, MG, 1995) |
| "Patients with bulimia nervosa have been reported to respond to treatment with the serotonin uptake inhibitor fluoxetine." | 5.08 | Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa. ( Linnoila, M; Naukkarinen, H; Rawlings, RR; Rissanen, A; Virkkunen, M, 1998) |
| "Three hundred eighty-two women meeting DSM-III-R criteria for bulimia nervosa participated in a multicenter, double-blind, randomized clinical trial of placebo, 20 mg of fluoxetine, and 60 mg of fluoxetine for 8 weeks." | 5.07 | Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change. ( Goldbloom, DS; Olmsted, MP, 1993) |
| "We administered an open trial of fluoxetine to 31 patients with DSM-III-R anorexia nervosa." | 5.07 | An open trial of fluoxetine in patients with anorexia nervosa. ( Bulik, CM; Hsu, LK; Kaye, WH; Weltzin, TE, 1991) |
| "In a double-blind trial 40 patients with bulimia nervosa according to DSM III-R criteria were randomly assigned either to a 60 mg fluoxetine group or to a placebo control group." | 5.07 | Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy. ( Brunner, E; Engel, RR; Fichter, MM; Leibl, K; Rief, W; Schmidt-Auberger, S, 1991) |
| "To determine whether fluoxetine is effective in the long-term treatment of obesity and whether it is particularly useful in the treatment of obese binge-eaters, the authors randomly assigned 45 obese subjects (22 with binge-eating problems and 23 without binge-eating) to fluoxetine (60 mg/day) or placebo in a 52-week double-blind trial." | 5.06 | A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. ( Ewing, L; Gooding, W; Kern, E; Marcus, MD; McDermott, M; Wing, RR, 1990) |
| "We describe three patients with concurrent DSM-III-R kleptomania and bulimia nervosa who all demonstrated a partial or complete response of both bulimic and kleptomanic symptoms to fluoxetine, trazodone, or tranylcypromine." | 5.06 | Pharmacological treatment of kleptomania and bulimia nervosa. ( Hudson, JI; Keck, PE; McElroy, SL; Pope, HG, 1989) |
| "Overall, this study revealed significant sex differences in the effects of fluoxetine and brain serotonin deficiency on binge-like food intake and suggests that low brain serotonin could impact eating disorders both by promoting binge eating and by limiting the efficacy of fluoxetine to reduce binge eating." | 4.12 | Brain serotonin deficiency and fluoxetine lead to sex-specific effects on binge-like food consumption in mice. ( Baugher, BJ; Huq, SN; Karth, MD; Karth, MM; Pellechia, SA; Sachs, BD; Warner, AK, 2022) |
| "The current study established whether vomiting bulimic and/or non-bulimic depressive patients, both treated with a serotonin reuptake inhibitor (fluoxetine), have changes in their whole salivary secretion and inorganic components: Na(+), K(+), Ca(2+)." | 3.77 | Flow rates and inorganic composition of whole saliva in purging bulimic patients treated with a fluoxetine. ( Linden, RW; Paszynska, E; Rajewski, A; Slopien, A, 2011) |
| "We examined the effect of fluoxetine to suppress binge eating in rats with a history of caloric restriction (CR) and the extent to which this effect was altered by stress and hunger." | 3.72 | Stress and hunger alter the anorectic efficacy of fluoxetine in binge-eating rats with a history of caloric restriction. ( Boggiano, MM; Chandler, PC; Maldonado, C; Oswald, KD; Placidi, RJ; Wauford, PK, 2004) |
| "Fluoxetine had a positive effect on bulimia nervosa but none on compulsive water drinking." | 3.70 | Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking. ( Dan, B; Fontaine, E; Kornreich, C; Pelc, I; Verbanck, P, 1998) |
| "We report on a 32-year old woman with bulimia nervosa treated with fluoxetine for depression." | 3.68 | Severe disturbance occurring during treatment for depression of a bulimic patient with fluoxetine. ( Hawthorne, ME; Lacey, JH, 1992) |
| "Data from United States Investigational New Drug double-blind, placebo-controlled fluoxetine clinical trials in bulimia nervosa were analyzed comprehensively to assess the potential association between fluoxetine treatment and suicidality in 785 patients with DSM-III-R bulimia nervosa." | 3.68 | Lack of association between fluoxetine and suicidality in bulimia nervosa. ( Beasley, CM; Masica, DN; Potvin, JH; Rampey, AH; Thompson, VL; Wheadon, DE, 1992) |
| "The results of a small study using fluoxetine in the treatment of bulimia nervosa are presented." | 3.67 | Fluoxetine as a treatment for bulimia nervosa. ( Freeman, CP; Hampson, M, 1987) |
| "Fluoxetine treatment was associated with greater reduction in depressive symptoms (p<0." | 2.71 | Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. ( Bellace, D; Carino, J; Devlin, MJ; Dobrow, I; Goldfein, JA; Jiang, H; Kamenetz, C; Mayer, L; Petkova, E; Raizman, PS; Walsh, BT; Wolk, S, 2005) |
| "Fluoxetine was not superior to placebo, CBT+fluoxetine and CBT+placebo did not differ, and both CBT conditions were superior to fluoxetine and to placebo." | 2.71 | Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. ( Grilo, CM; Masheb, RM; Wilson, GT, 2005) |
| " Fluoxetine at 20 mg/d produced an effect between that of the 60-mg/d dosage and that of placebo." | 2.67 | Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. ( , 1992) |
| "The fluoxetine treatment is not instead of, but in addition to the traditional behavioral treatment with strict limits regarding food and meals." | 2.67 | Drugs in the treatment of bulimia nervosa. ( Trygstad, O, 1990) |
| "A number of symptoms associated with eating disorders overlap those of depression and OCD, suggesting a theoretical and practical case for evaluating the SSRIs in the treatment of anorexia nervosa, bulimia nervosa, binge-eating disorder, and obesity." | 2.40 | The use of selective serotonin reuptake inhibitors in eating disorders. ( Mayer, LE; Walsh, BT, 1998) |
| "Binge eating is a dysregulated form of feeding behavior that occurs in multiple eating disorders including binge-eating disorder, the most common eating disorder." | 1.43 | Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating. ( Bulik, CM; Diberto, JF; Hardaway, JA; Hwa, LS; Jensen, J; Kash, TL; Kim, M; Lowery-Gionta, EG; Mazzone, CM; Pleil, KE; Sugam, JA, 2016) |
| "Cyproheptadine has been used to counteract these side effects." | 1.28 | Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. ( Goldbloom, DS; Kennedy, SH, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (3.57) | 18.7374 |
| 1990's | 52 (61.90) | 18.2507 |
| 2000's | 21 (25.00) | 29.6817 |
| 2010's | 6 (7.14) | 24.3611 |
| 2020's | 2 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Karth, MD | 1 |
| Baugher, BJ | 1 |
| Pellechia, SA | 1 |
| Huq, SN | 1 |
| Warner, AK | 1 |
| Karth, MM | 1 |
| Sachs, BD | 1 |
| Yu, S | 1 |
| Zhang, Y | 1 |
| Shen, C | 1 |
| Shao, F | 1 |
| Paszynska, E | 2 |
| Linden, RW | 2 |
| Slopien, A | 2 |
| Rajewski, A | 2 |
| Bello, NT | 1 |
| Yeh, CY | 1 |
| Verpeut, JL | 1 |
| Walters, AL | 1 |
| Hardaway, JA | 1 |
| Jensen, J | 1 |
| Kim, M | 1 |
| Mazzone, CM | 1 |
| Sugam, JA | 1 |
| Diberto, JF | 1 |
| Lowery-Gionta, EG | 1 |
| Hwa, LS | 1 |
| Pleil, KE | 1 |
| Bulik, CM | 4 |
| Kash, TL | 1 |
| Xu, P | 1 |
| He, Y | 1 |
| Cao, X | 1 |
| Valencia-Torres, L | 1 |
| Yan, X | 1 |
| Saito, K | 1 |
| Wang, C | 1 |
| Yang, Y | 1 |
| Hinton, A | 1 |
| Zhu, L | 1 |
| Shu, G | 1 |
| Myers, MG | 1 |
| Wu, Q | 1 |
| Tong, Q | 1 |
| Heisler, LK | 1 |
| Xu, Y | 1 |
| Cifani, C | 1 |
| Polidori, C | 1 |
| Melotto, S | 1 |
| Ciccocioppo, R | 1 |
| Massi, M | 1 |
| Hay, PJ | 2 |
| Claudino, AM | 1 |
| Arnold, LM | 1 |
| McElroy, SL | 3 |
| Hudson, JI | 4 |
| Welge, JA | 1 |
| Bennett, AJ | 1 |
| Keck, PE | 4 |
| Tammela, LI | 1 |
| Rissanen, A | 2 |
| Kuikka, JT | 1 |
| Karhunen, LJ | 1 |
| Bergström, KA | 1 |
| Repo-Tiihonen, E | 1 |
| Naukkarinen, H | 2 |
| Vanninen, E | 1 |
| Tiihonen, J | 1 |
| Uusitupa, M | 1 |
| Kotler, LA | 1 |
| Devlin, MJ | 5 |
| Davies, M | 1 |
| Walsh, BT | 11 |
| Ricca, V | 1 |
| Mannucci, E | 1 |
| Mezzani, B | 1 |
| Di Bernardo, M | 1 |
| Barciulli, E | 1 |
| Moretti, S | 1 |
| Cabras, PL | 1 |
| Rotella, CM | 1 |
| McDermott, C | 1 |
| Agras, WS | 2 |
| Crow, SJ | 1 |
| Halmi, K | 1 |
| Mitchell, JE | 3 |
| Bryson, S | 1 |
| Fairburn, CG | 3 |
| Mickley, D | 1 |
| Sysko, R | 2 |
| Parides, MK | 1 |
| Joyce, PR | 1 |
| Luty, SE | 1 |
| McKenzie, JM | 1 |
| Mulder, RT | 1 |
| McIntosh, VV | 1 |
| Carter, FA | 1 |
| Sullivan, PF | 1 |
| Placidi, RJ | 1 |
| Chandler, PC | 1 |
| Oswald, KD | 2 |
| Maldonado, C | 1 |
| Wauford, PK | 1 |
| Boggiano, MM | 2 |
| Grilo, CM | 1 |
| Masheb, RM | 1 |
| Wilson, GT | 4 |
| Goldfein, JA | 2 |
| Petkova, E | 3 |
| Jiang, H | 1 |
| Raizman, PS | 1 |
| Wolk, S | 1 |
| Mayer, L | 1 |
| Carino, J | 1 |
| Bellace, D | 1 |
| Kamenetz, C | 1 |
| Dobrow, I | 1 |
| Hazen, E | 1 |
| Fava, M | 1 |
| Theleritis, CG | 1 |
| Papadimitriou, GN | 1 |
| Papageorgiou, CC | 1 |
| Dikeos, DG | 1 |
| Masdrakis, V | 1 |
| Kostoulas, C | 1 |
| Psarros, C | 1 |
| Soldatos, CR | 1 |
| Chandler-Laney, PC | 1 |
| Castañeda, E | 1 |
| Viana, JB | 1 |
| Maldonado, CR | 1 |
| Liu, L | 1 |
| Brambilla, F | 1 |
| Draisci, A | 1 |
| Peirone, A | 1 |
| Brunetta, M | 1 |
| Goldstein, DJ | 2 |
| Wilson, MG | 2 |
| Thompson, VL | 2 |
| Potvin, JH | 3 |
| Rampey, AH | 3 |
| Weltzin, TE | 2 |
| McCabe, E | 1 |
| Flynn, D | 1 |
| Kaye, W | 2 |
| Berk, M | 1 |
| Vaz, FJ | 1 |
| Salcedo, MS | 1 |
| McCarthy, MK | 1 |
| Goff, DC | 1 |
| Baer, L | 1 |
| Cioffi, J | 1 |
| Herzog, DB | 1 |
| Schwitzer, J | 1 |
| Neudorfer, C | 1 |
| Fleischhacker, WW | 1 |
| Wood, A | 1 |
| Ceccherini-Nelli, A | 1 |
| Guidi, L | 1 |
| Tollefson, GD | 1 |
| Fawcett, J | 1 |
| Winokur, G | 1 |
| Beasley, CM | 2 |
| Faries, DE | 1 |
| Sayler, ME | 1 |
| Brown, K | 1 |
| Henderson, T | 1 |
| Waller, DA | 1 |
| Gullion, CM | 1 |
| Petty, F | 1 |
| Hardy, BW | 1 |
| Murdock, MV | 1 |
| Rush, AJ | 1 |
| Parkin, JR | 1 |
| Eagles, JM | 1 |
| Goldbloom, DS | 3 |
| Olmsted, MP | 1 |
| Bretz, WA | 1 |
| Krahn, DD | 1 |
| Drury, M | 1 |
| Schork, N | 1 |
| Loesche, WJ | 1 |
| Pijl, H | 1 |
| Cohen, AF | 1 |
| Verkes, RJ | 1 |
| Koppeschaar, HP | 1 |
| Iestra, JA | 1 |
| Schoemaker, HC | 1 |
| Frölich, M | 1 |
| Onkenhout, W | 1 |
| Meinders, AE | 1 |
| Jarry, JL | 1 |
| Vaccarino, FJ | 1 |
| Carter, WP | 1 |
| Pope, HG | 2 |
| McGown, A | 1 |
| Whitbread, J | 1 |
| Loeb, KL | 2 |
| Pike, KM | 1 |
| Roose, SP | 1 |
| Fleiss, J | 1 |
| Waternaux, C | 2 |
| Beumont, PJ | 1 |
| Russell, JD | 1 |
| Touyz, SW | 1 |
| Buckley, C | 1 |
| Lowinger, K | 1 |
| Talbot, P | 1 |
| Johnson, GF | 1 |
| Olmsted, M | 1 |
| Davis, R | 1 |
| Clewes, J | 1 |
| Heinmaa, M | 1 |
| Rockert, W | 1 |
| Shaw, B | 1 |
| Virkkunen, M | 1 |
| Rawlings, RR | 1 |
| Linnoila, M | 1 |
| Kornreich, C | 1 |
| Dan, B | 1 |
| Verbanck, P | 1 |
| Fontaine, E | 1 |
| Pelc, I | 1 |
| Mayer, LE | 1 |
| Cookson, J | 1 |
| Duffett, R | 1 |
| Ascroft, RC | 1 |
| al-Banna, M | 2 |
| Crow, S | 1 |
| Mussell, MP | 2 |
| Peterson, C | 1 |
| Knopke, A | 1 |
| Mitchell, J | 1 |
| Tauscher, J | 1 |
| Pirker, W | 1 |
| de Zwaan, M | 1 |
| Asenbaum, S | 1 |
| Brücke, T | 1 |
| Kasper, S | 1 |
| Neumeister, A | 1 |
| Winkler, A | 1 |
| Wöber-Bingöl, C | 1 |
| Labouvie, E | 1 |
| Liu, X | 1 |
| Kahn, C | 1 |
| Chally, MK | 1 |
| Lam, RW | 1 |
| Lee, SK | 1 |
| Tam, EM | 1 |
| Grewal, A | 1 |
| Yatham, LN | 1 |
| Fletcher, L | 1 |
| Hanson, K | 1 |
| Seim, H | 1 |
| Crosby, R | 1 |
| Kane, JM | 1 |
| Romano, SJ | 1 |
| Halmi, KA | 1 |
| Sarkar, NP | 1 |
| Koke, SC | 1 |
| Lee, JS | 1 |
| Hawthorne, ME | 1 |
| Lacey, JH | 1 |
| Brewerton, TD | 1 |
| Shannon, M | 1 |
| Oliveros, SC | 1 |
| Iruela, LM | 1 |
| Caballero, L | 1 |
| Baca, E | 1 |
| Wheadon, DE | 1 |
| Masica, DN | 1 |
| Iancu, I | 1 |
| Ratzoni, G | 1 |
| Weitzman, A | 1 |
| Apter, A | 1 |
| Kaye, WH | 1 |
| Hsu, LK | 1 |
| Fichter, MM | 1 |
| Leibl, K | 1 |
| Rief, W | 1 |
| Brunner, E | 1 |
| Schmidt-Auberger, S | 1 |
| Engel, RR | 1 |
| Nguyen, T | 1 |
| Middleton, RK | 1 |
| Dorsey, CM | 1 |
| Campbell, PI | 1 |
| Kennedy, SH | 1 |
| Epstein, LH | 1 |
| Ramirez, LC | 1 |
| Rosenstock, J | 1 |
| Strowig, S | 1 |
| Cercone, S | 1 |
| Raskin, P | 1 |
| Marcus, MD | 1 |
| Wing, RR | 1 |
| Ewing, L | 1 |
| Kern, E | 1 |
| McDermott, M | 1 |
| Gooding, W | 1 |
| Lyles, B | 1 |
| Sarkis, E | 1 |
| Kemph, JP | 1 |
| Solyom, L | 1 |
| Solyom, C | 1 |
| Ledwidge, B | 1 |
| Trygstad, O | 1 |
| Pyle, RL | 1 |
| Eckert, ED | 1 |
| Hatsukami, D | 1 |
| Pomeroy, C | 1 |
| Zimmerman, R | 1 |
| Freeman, CP | 1 |
| Hampson, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans With Eating Disorders (EASED Study)[NCT05304104] | 144 participants (Anticipated) | Interventional | 2022-04-22 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for fluoxetine and Bulimia
| Article | Year |
|---|---|
Efficacy of pharmacotherapies for bulimia nervosa: a systematic review and meta-analysis.
Topics: Bulimia; Bulimia Nervosa; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Vomiting | 2023 |
Bulimia nervosa.
Topics: Administration, Oral; Bulimia; Bulimia Nervosa; Cognitive Behavioral Therapy; Evidence-Based Medicin | 2010 |
Understanding bulimia.
Topics: Adult; Antidepressive Agents; Bulimia; Cognitive Behavioral Therapy; Evidence-Based Medicine; Family | 2007 |
Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.
Topics: Antidepressive Agents, Tricyclic; Bulimia; Clinical Trials as Topic; Depressive Disorder; Double-Bli | 1993 |
Eating disorder and obsessive-compulsive disorder: neurochemical and phenomenological commonalities.
Topics: Anorexia Nervosa; Bulimia; Clomipramine; Comorbidity; Female; Fluoxetine; Humans; Male; Obsessive-Co | 1996 |
Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Body Weight; Bulimia; Clinical Trials as To | 1996 |
Out of control! the most effective way to help the binge-eating patient.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bulimia; Cognitive Behavioral Therapy; D | 1996 |
The use of selective serotonin reuptake inhibitors in eating disorders.
Topics: Anorexia Nervosa; Antidepressive Agents; Bulimia; Clinical Trials as Topic; Combined Modality Therap | 1998 |
Fluoxetine: therapeutic and undesirable effects.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bulimia; Child; Drug Interactions; Fluo | 1998 |
Psychopharmacologic treatment of bulimia nervosa.
Topics: Antidepressive Agents, Tricyclic; Bulimia; Clinical Trials as Topic; Double-Blind Method; Drug Admin | 1991 |
Fluoxetine in bulimia.
Topics: Adult; Bulimia; Female; Fluoxetine; Humans; Remission Induction | 1991 |
Fluoxetine treatment of bulimia nervosa.
Topics: Antidepressive Agents; Bulimia; Fluoxetine; Follow-Up Studies; Humans | 1991 |
40 trials available for fluoxetine and Bulimia
| Article | Year |
|---|---|
Parotid gland flow activity and inorganic composition in purging bulimic patients treated with fluoxetine.
Topics: Adult; Bipolar Disorder; Bulimia; Calcium; Female; Fluoxetine; Humans; Parotid Gland; Potassium; Sal | 2013 |
A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.
Topics: Adult; Body Mass Index; Body Weight; Bulimia; Dose-Response Relationship, Drug; Double-Blind Method; | 2002 |
Treatment improves serotonin transporter binding and reduces binge eating.
Topics: Adult; Bulimia; Carrier Proteins; Female; Fluoxetine; Humans; Membrane Glycoproteins; Membrane Trans | 2003 |
An open trial of fluoxetine for adolescents with bulimia nervosa.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Anxiety; Body Mass Index; Bulimia; Depressive | 2003 |
Cognitive-behavioral therapy versus combined treatment with group psychoeducation and fluoxetine in bulimic outpatients.
Topics: Adult; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Health | 1997 |
Participant recruitment for an anorexia nervosa treatment study.
Topics: Adolescent; Adult; Anorexia Nervosa; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therap | 2004 |
Treatment of bulimia nervosa in a primary care setting.
Topics: Adult; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Humans; | 2004 |
Bipolar II disorder: personality and outcome in two clinical samples.
Topics: Adrenergic Uptake Inhibitors; Adult; Bipolar Disorder; Bulimia; Cognitive Behavioral Therapy; Depres | 2004 |
Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia; Cognitive Behavioral Therapy; Cross-Over S | 2005 |
Eating Disorder Examination-Questionnaire as a measure of change in patients with bulimia nervosa.
Topics: Adolescent; Adult; Bulimia; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Meth | 2005 |
Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia; Cognitive Behavioral Therapy; Double-Blind | 2005 |
Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Body Mass Index | 2007 |
Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxie | 1995 |
Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group.
Topics: Adolescent; Adult; Appetite Regulation; Bulimia; Double-Blind Method; Feeding Behavior; Female; Fluo | 1995 |
Dissociation, childhood trauma, and the response to fluoxetine in bulimic patients.
Topics: Adolescent; Adult; Bulimia; Child; Child Abuse; Child Abuse, Sexual; Child, Preschool; Dissociative | 1994 |
Pharmacotherapy of bulimia nervosa--experience with fluoxetine.
Topics: Adult; Bulimia; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Feeding | 1993 |
Fluoxetine: the relationship between response, adverse events, and plasma concentrations in the treatment of bulimia nervosa.
Topics: Adult; Bulimia; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans | 1993 |
Tridimensional Personality Questionnaire and serotonin in bulimia nervosa.
Topics: Adult; Arousal; Bulimia; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Humans; Middle | 1993 |
Pharmacotherapy of bulimia nervosa with fluoxetine: assessment of clinically significant attitudinal change.
Topics: Adult; Attitude; Bulimia; Depressive Disorder; Double-Blind Method; Feeding Behavior; Female; Fluoxe | 1993 |
Effects of fluoxetine on the oral environment of bulimics.
Topics: Analysis of Variance; Bulimia; Colony Count, Microbial; Double-Blind Method; Female; Fluoxetine; Hum | 1993 |
Plasma amino acid ratios related to brain serotonin synthesis in response to food intake in bulimia nervosa.
Topics: Adult; Amino Acids; Analysis of Variance; Blood Glucose; Brain; Bulimia; Cross-Over Studies; Dietary | 1995 |
Medication and psychotherapy in the treatment of bulimia nervosa.
Topics: Adolescent; Adult; Bulimia; Cognitive Behavioral Therapy; Combined Modality Therapy; Desipramine; Do | 1997 |
Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?
Topics: Adolescent; Adult; Bulimia; Combined Modality Therapy; Counseling; Dose-Response Relationship, Drug; | 1997 |
A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bulimia; Chi-Square Distribution; Cogni | 1997 |
Fluoxetine normalizes increased cardiac vagal tone in bulimia nervosa.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia; Double-Blind Method; Electrocardiography; | 1998 |
Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia; Comorbidity; Depressive Disorder; Double-B | 1999 |
In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment.
Topics: Adolescent; Aged; Antidepressive Agents, Second-Generation; Brain; Brain Chemistry; Bulimia; Carrier | 1999 |
Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change.
Topics: Adolescent; Adult; Antidepressive Agents; Bulimia; Cognitive Behavioral Therapy; Desipramine; Female | 1999 |
Fluoxetine for bulimia nervosa following poor response to psychotherapy.
Topics: Adult; Bulimia; Cognitive Behavioral Therapy; Drug Administration Schedule; Female; Fluoxetine; Huma | 2000 |
An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.
Topics: Adolescent; Adult; Bulimia; Comorbidity; Female; Fluoxetine; Fluvoxamine; Humans; Multi-Institutiona | 2001 |
The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Bulimia; Fluoxeti | 2001 |
A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment.
Topics: Adolescent; Adult; Bulimia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetin | 2002 |
Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group.
Topics: Adult; Ambulatory Care; Body Mass Index; Bulimia; Dose-Response Relationship, Drug; Double-Blind Met | 1992 |
An open trial of fluoxetine in patients with anorexia nervosa.
Topics: Adolescent; Adult; Ambulatory Care; Anorexia Nervosa; Body Weight; Bulimia; Female; Fluoxetine; Foll | 1991 |
Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy.
Topics: Adult; Body Weight; Bulimia; Double-Blind Method; Female; Fluoxetine; Humans; Male; Psychiatric Stat | 1991 |
Treatment of laxative abuse in a female with bulimia nervosa using an operant extinction paradigm.
Topics: Adult; Behavior Therapy; Bulimia; Cathartics; Cognitive Behavioral Therapy; Combined Modality Therap | 1990 |
A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters.
Topics: Adolescent; Adult; Attitude to Health; Behavior Therapy; Bulimia; Clinical Trials as Topic; Combined | 1990 |
Drugs in the treatment of bulimia nervosa.
Topics: Bulimia; Combined Modality Therapy; Depressive Disorder; Female; Fluoxetine; Humans; Psychotropic Dr | 1990 |
Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa.
Topics: Adolescent; Adult; Antidepressive Agents; Bulimia; Clinical Trials as Topic; Desipramine; Feeding Be | 1989 |
Pharmacological treatment of kleptomania and bulimia nervosa.
Topics: Adult; Bulimia; Clinical Trials as Topic; Disruptive, Impulse Control, and Conduct Disorders; Drug T | 1989 |
32 other studies available for fluoxetine and Bulimia
| Article | Year |
|---|---|
Brain serotonin deficiency and fluoxetine lead to sex-specific effects on binge-like food consumption in mice.
Topics: Animals; Binge-Eating Disorder; Brain; Bulimia; Female; Fluoxetine; Male; Mice; Serotonin | 2022 |
Binge-like eating attenuates nisoxetine feeding suppression, stress activation, and brain norepinephrine activity.
Topics: Animals; Body Weight; Brain; Bulimia; Energy Intake; Feeding Behavior; Fluoxetine; Male; Norepinephr | 2014 |
Nociceptin receptor antagonist SB 612111 decreases high fat diet binge eating.
Topics: Adaptation, Ocular; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Bulimia | 2016 |
Activation of Serotonin 2C Receptors in Dopamine Neurons Inhibits Binge-like Eating in Mice.
Topics: Animals; Benzazepines; Bulimia; Dopaminergic Neurons; Eating; Female; Fluoxetine; Male; Mice; Mice, | 2017 |
A preclinical model of binge eating elicited by yo-yo dieting and stressful exposure to food: effect of sibutramine, fluoxetine, topiramate, and midazolam.
Topics: Animals; Appetite Depressants; Behavior, Animal; Bulimia; Cyclobutanes; Disease Models, Animal; Eati | 2009 |
Flow rates and inorganic composition of whole saliva in purging bulimic patients treated with a fluoxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia; Calcium; Colorimetry; Depression; Electrol | 2011 |
Stress and hunger alter the anorectic efficacy of fluoxetine in binge-eating rats with a history of caloric restriction.
Topics: Animals; Anorexia; Bulimia; Energy Intake; Female; Fluoxetine; Hunger; Injections, Intraperitoneal; | 2004 |
Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Bulimia; Drug Resistance; Duloxetine Hyd | 2006 |
Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bulimia; Depression; Diabetes | 2006 |
A history of human-like dieting alters serotonergic control of feeding and neurochemical balance in a rat model of binge-eating.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents, Second-Generation; Brain; Bulimia; D | 2007 |
Anorexia and bulimia nervosa: psychiatric approach.
Topics: Anorexia Nervosa; Antidepressive Agents; Bulimia; Cyproheptadine; Fluoxetine; Humans; Nutritional Ph | 1994 |
Fluoxetine and social phobia.
Topics: Adult; Bulimia; Depressive Disorder; Female; Fluoxetine; Humans; Middle Aged; Phobic Disorders | 1995 |
Fluoxetine-induced anorexia in a bulimic patient with antecedents of anorexia nervosa.
Topics: Adult; Anorexia; Anorexia Nervosa; Bulimia; Drug Administration Schedule; Female; Fluoxetine; Humans | 1994 |
Seasonal bulimia treated with fluoxetine and phototherapy.
Topics: Adult; Bulimia; Combined Modality Therapy; Female; Fluoxetine; Humans; Phototherapy; Seasons | 1993 |
Blood-letting in bulimia nervosa.
Topics: Adult; Bloodletting; Bulimia; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Self Mut | 1993 |
Blood-letting in bulimia nervosa.
Topics: Adult; Bloodletting; Bulimia; Child of Impaired Parents; Combined Modality Therapy; Depressive Disor | 1993 |
Divergent responses to fluoxetine from two compulsive, food-related conditions: bulimia nervosa and compulsive water drinking.
Topics: Adult; Antidepressive Agents, Second-Generation; Bulimia; Compulsive Personality Disorder; Drinking; | 1998 |
Prior treatment received by patients with bulimia nervosa.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bulimia; Cognitive Behavioral Therapy; | 1999 |
Addition of naltrexone to fluoxetine in the treatment of binge eating disorder.
Topics: Adolescent; Bulimia; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine | 1999 |
Extending indications for long-term pharmacotherapy: opportunities and challenges.
Topics: Bulimia; Chronic Disease; Fluoxetine; Humans; Long-Term Care; Obsessive-Compulsive Disorder; Sertral | 2002 |
Severe disturbance occurring during treatment for depression of a bulimic patient with fluoxetine.
Topics: Adult; Bulimia; Depressive Disorder; Female; Fluoxetine; Humans; Paranoid Disorders; Self-Injurious | 1992 |
Possible clozapine exacerbation of bulimia nervosa.
Topics: Acute Disease; Adult; Bulimia; Clozapine; Dyskinesia, Drug-Induced; Female; Fluoxetine; Humans; Recu | 1992 |
Ratio of plasma fluoxetine to norfluoxetine concentrations and associated sedation.
Topics: Adult; Bulimia; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; | 1992 |
Fluoxetine-induced anorexia in a bulimic patient.
Topics: Adult; Amenorrhea; Anorexia Nervosa; Bulimia; Female; Fluoxetine; Humans; Recurrence; Weight Gain | 1992 |
Lack of association between fluoxetine and suicidality in bulimia nervosa.
Topics: Adolescent; Adult; Aged; Bulimia; Clinical Trials as Topic; Double-Blind Method; Female; Fluoxetine; | 1992 |
More fluoxetine experience.
Topics: Adolescent; Bulimia; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Gala | 1992 |
Effect of fluoxetine on sleep.
Topics: Adult; Arousal; Bulimia; Depressive Disorder; Female; Fluoxetine; Humans; Sleep Initiation and Maint | 1991 |
Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa.
Topics: Adult; Bulimia; Cyproheptadine; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Hu | 1991 |
Effective treatment of bulimia with fluoxetine, a serotonin reuptake inhibitor, in a patient with type I diabetes mellitus.
Topics: Adult; Bulimia; Diabetes Mellitus, Type 1; Female; Fluoxetine; Humans; Neurotransmitter Uptake Inhib | 1990 |
Fluoxetine and anorexia.
Topics: Adolescent; Anorexia Nervosa; Bulimia; Combined Modality Therapy; Depressive Disorder; Female; Fluox | 1990 |
The fluoxetine treatment of low-weight, chronic bulimia nervosa.
Topics: Adult; Anxiety Disorders; Body Weight; Bulimia; Depressive Disorder; Feeding Behavior; Female; Fluox | 1990 |
Fluoxetine as a treatment for bulimia nervosa.
Topics: Adult; Antidepressive Agents; Bulimia; Female; Fluoxetine; Follow-Up Studies; Humans; Middle Aged; P | 1987 |